Your browser doesn't support javascript.
loading
Artificial intelligence in liver diseases: Improving diagnostics, prognostics and response prediction.
Nam, David; Chapiro, Julius; Paradis, Valerie; Seraphin, Tobias Paul; Kather, Jakob Nikolas.
Affiliation
  • Nam D; Section of Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
  • Chapiro J; Section of Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
  • Paradis V; INSERM U1149 "Centre de Recherche Sur L'inflammation", CRI, Université de Paris, Paris, France.
  • Seraphin TP; University Paris, AP-HP, Department of Pathology, Hôpital Beaujon, Clichy, France.
  • Kather JN; Department of Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty of Heinrich Heine University Düsseldorf, University Hospital Düsseldorf, Düsseldorf, Germany.
JHEP Rep ; 4(4): 100443, 2022 Apr.
Article de En | MEDLINE | ID: mdl-35243281
ABSTRACT
Clinical routine in hepatology involves the diagnosis and treatment of a wide spectrum of metabolic, infectious, autoimmune and neoplastic diseases. Clinicians integrate qualitative and quantitative information from multiple data sources to make a diagnosis, prognosticate the disease course, and recommend a treatment. In the last 5 years, advances in artificial intelligence (AI), particularly in deep learning, have made it possible to extract clinically relevant information from complex and diverse clinical datasets. In particular, histopathology and radiology image data contain diagnostic, prognostic and predictive information which AI can extract. Ultimately, such AI systems could be implemented in clinical routine as decision support tools. However, in the context of hepatology, this requires further large-scale clinical validation and regulatory approval. Herein, we summarise the state of the art in AI in hepatology with a particular focus on histopathology and radiology data. We present a roadmap for the further development of novel biomarkers in hepatology and outline critical obstacles which need to be overcome.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Diagnostic_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Langue: En Journal: JHEP Rep Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Diagnostic_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Langue: En Journal: JHEP Rep Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique